Clinical Trial Update: Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and potential bioactivity of CLBS16 in patients with coronary microvascular dysfunction and no obstructive coronary arte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Microvascular Dysfunction

Drugs mentioned

• CLBS16

Snippet

Sponsor: Lisata Therapeutics, Inc. | Conditions: Coronary Microvascular Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2021-01-08